IRIS
COSTA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.956
NA - Nord America 3.829
AS - Asia 2.074
SA - Sud America 648
Continente sconosciuto - Info sul continente non disponibili 287
AF - Africa 94
OC - Oceania 1
Totale 10.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.657
RU - Federazione Russa 2.244
SG - Singapore 884
BR - Brasile 536
IT - Italia 466
CN - Cina 453
IE - Irlanda 410
HK - Hong Kong 258
SE - Svezia 229
VN - Vietnam 166
DE - Germania 133
FR - Francia 91
GB - Regno Unito 77
CA - Canada 75
FI - Finlandia 71
IN - India 67
PL - Polonia 64
AT - Austria 47
BD - Bangladesh 47
AR - Argentina 38
MX - Messico 37
ES - Italia 24
MA - Marocco 24
TR - Turchia 24
ID - Indonesia 23
ZA - Sudafrica 21
NL - Olanda 20
UA - Ucraina 20
CO - Colombia 18
EC - Ecuador 18
IQ - Iraq 18
UZ - Uzbekistan 18
JP - Giappone 17
BE - Belgio 14
MY - Malesia 14
JM - Giamaica 13
PK - Pakistan 13
CR - Costa Rica 10
TN - Tunisia 10
EG - Egitto 9
KE - Kenya 9
LT - Lituania 9
PY - Paraguay 9
VE - Venezuela 9
IL - Israele 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
SC - Seychelles 7
BO - Bolivia 6
CL - Cile 6
CZ - Repubblica Ceca 6
GT - Guatemala 6
NP - Nepal 6
SA - Arabia Saudita 6
HN - Honduras 5
KZ - Kazakistan 5
OM - Oman 5
PH - Filippine 5
PT - Portogallo 5
SN - Senegal 5
CH - Svizzera 4
GP - Guadalupe 4
LB - Libano 4
PE - Perù 4
TH - Thailandia 4
AL - Albania 3
BB - Barbados 3
DK - Danimarca 3
EE - Estonia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
DZ - Algeria 2
GY - Guiana 2
HR - Croazia 2
MT - Malta 2
NG - Nigeria 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SV - El Salvador 2
UY - Uruguay 2
VC - Saint Vincent e Grenadine 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
ET - Etiopia 1
EU - Europa 1
HT - Haiti 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 10.594
Salva come PNG Salva come JPEG
Città #
Ashburn 665
Moscow 654
Singapore 434
Dublin 410
San Jose 299
Dallas 283
Hong Kong 253
Chandler 186
Nyköping 165
Council Bluffs 163
Messina 115
Beijing 107
The Dalles 92
Los Angeles 85
Ho Chi Minh City 66
Santa Clara 66
New York 62
Warsaw 60
Munich 57
São Paulo 47
Rome 46
Lauterbourg 45
Phoenix 40
Hanoi 34
Dearborn 32
Buffalo 30
Vienna 30
Milan 29
Bremen 26
Jacksonville 26
Princeton 26
Redondo Beach 26
Ann Arbor 25
Tianjin 24
Chicago 23
Medford 23
Des Moines 22
Montreal 22
Columbus 21
Shanghai 21
Denver 20
London 20
Helsinki 19
Brasília 18
Tashkent 18
Turku 18
Brooklyn 17
Chennai 17
Frankfurt am Main 17
Houston 17
Orem 17
Rio de Janeiro 17
Belo Horizonte 15
Boardman 15
Guangzhou 15
Atlanta 14
Brussels 14
Lappeenranta 14
Nuremberg 14
Tokyo 14
Amsterdam 13
Catania 12
North Bergen 12
Washington 12
Campinas 11
Naples 11
Newark 11
Boston 10
Cambridge 10
Manchester 10
Mexico City 10
Porto Alegre 10
San Francisco 10
San José 10
Springfield 10
Toronto 10
Düsseldorf 9
Hangzhou 9
Pune 9
Quito 9
San Marcellino 9
Stockholm 9
Suffern 9
Cagliari 8
Hillsboro 8
Jakarta 8
Nairobi 8
Nanjing 8
Salvador 8
Ankara 7
Da Nang 7
Fort Worth 7
Goiânia 7
Hyderabad 7
Johannesburg 7
Kingston 7
Kuala Lumpur 7
Los Lunas 7
New Delhi 7
Philadelphia 7
Totale 5.530
Salva come PNG Salva come JPEG
Nome #
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI 315
Correlations between genetic mutations, biomolecular patterns and elastic properties of the aorta in patients with bicuspid aortic valve. 268
686 Coronary lesion distribution in young patient presenting with acute coronary syndrome 224
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 213
752 Acute coronary syndrome in young patients: long-term follow-up and quality of life assessment 199
Fibrosis after Myocardial Infarction: An Overview on Cellular Processes, Molecular Pathways, Clinical Evaluation and Prognostic Value 196
A Very Late Atrial Septal Erosion After an Ostium Secundum Percutaneous Closure 195
A meta-analysis of 22108 patients undergoing PCI: can radial approach reduce the incidence of acute kidney injury? 192
Elastin and aortopathy in bicuspid aortic valve: correlations between genetic and biomolecular patterns and mechanical properties of the aorta 191
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways 190
Impellent impeller-Switching intra-aortic balloon pump to IMPELLA-CP after ST-segment elevation myocardial infarction and refractory cardiogenic shock 187
Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management—A Narrative Review 184
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial 182
Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies-meta-analysis of prospective studies 176
P1468Non-invasive myocardial work indices in ischemic heart disease 176
Radial Artery Access for Percutaneous Cardiovascular Interventions: Contemporary Insights and Novel Approaches 171
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 165
57 ISCHEMIC HEART SCOMBROID SYNDROME: FURTHER EVIDENCE FROM ALL OVER THE WORLD 159
Percutaneous Coronary Intervention before or after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Involving 1531 Patients 154
Benefit of radial approach in reducing the incidence of acute kidney injury after percutaneous coronary intervention: A meta-analysis of 22,108 patients 152
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 149
Appraising the counter-balancing ischemia and bleeding risks for dual antiplatelet therapy duration after coronary stenting 147
A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making 146
Analysis of changes in "mitral valve reserve" after coronary artery bypass grafts in patients with functional mitral regurgitation 139
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: Results of an EAPCI survey 138
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management 137
External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis 137
Echocardiographic Evolution of PosteroLateral Left Ventricular Aneurysm with Normal Coronary Arteries in Patient Recently COVID-19 Vaccinated: A Complicated Atypical Case of Takotsubo Syndrome Vaccine-related? 135
Antithrombotic therapy for percutaneous cardiovascular interventions: From coronary artery disease to structural heart interventions 135
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation 133
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 131
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI 126
Alcohol septal ablation: An option on the rise in hypertrophic obstructive cardiomyopathy 124
Chest Pain and the Dynamic Evolution of Spontaneous Coronary Artery Hematoma 124
Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials 123
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 122
Left Main Coronary Artery 119
Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study 118
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 118
The High Bleeding Risk Patient with Coronary Artery Disease 117
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 113
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 112
Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy 112
Mental health status and sexual habits in young patient after acute coronary syndrome 112
MVP ECG risk score predicts early occurrence of atrial fibrillation after patent foramen ovale percutaneous closure 109
ELECTRICAL STORM IN ISCHAEMIC HEART DISEASE: A CASE OF LEFT STELLATE GANGLION BLOCK AS BRIDGE TO URGENT PCI RESCUE 109
Bleeding risk in patients undergoing percutaneous coronary intervention: how to define, identify and treat high-risk patients 106
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 105
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 105
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 103
Impact of vascular access on acute kidney injury after percutaneous coronary intervention 103
Distribution of wall motion abnormalities in young patients presenting with acute coronary syndrome 101
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 98
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS 98
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease 91
Exploring the Incremental Value of CRUSADE Score as Clinical Guidance for the Decision-Making of Dual Antiplatelet Therapy Duration: A Retrospective Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial Pathway 90
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 89
In-stent restenosis of superficial femoral artery: use all arrows in the quiver 89
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease 89
Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials 89
Impact of a 24- rather than 6-month dual antiplatelet therapy with clopidogrel in patients with left main or proximal left anterior descending coronary artery disease. A post hoc analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent ­Induced Intimal Hyperplasia) PRODIGY trial 89
Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach? 89
Anatomic Characteristics and Clinical Implications of Angiographic Coronary Thrombus 87
Catheter-based techniques for pulmonary embolism treatment 85
Moderate conscious sedation for transesophageal echocardiography guidance of percutaneous left atrial appendage closure: The MID-DEX protocol 85
Advances in Acute Coronary Syndromes: Bridging Gaps in Diagnosis and Treatment 85
A Look Beyond Statins and Ezetimibe: a Review of Other Lipid-Lowering Treatments for Cardiovascular Disease Prevention in High-Risk Patients 84
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 79
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 75
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization 72
Impact of Clinical Presentation on Ischemic and Bleeding Outcomes in Patients Receiving 6 or 24 Month Duration of Dual Antiplatelet Therapy After Stent Implantation: A Pre-Specified Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial 71
Advanced Management of Patients Undergoing Transcatheter Treatment for Pulmonary Embolism: Evidence-Based Strategies for Optimized Patient Care 61
Vacuum-assisted thrombectomy of massive inferior vena cava thrombosis 61
Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis 57
Aspirin-Free Strategy After ACS Implementing Colchicine: Looking for a Substitution? 51
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial 51
Chronic Thrombocytopenia and Percutaneous Coronary Intervention: The Virtue of Prudence ∗ 49
Characterization of the Individual Patient Risk After Percutaneous Coronary Intervention: At the Crossroads of Bleeding and Thrombosis 47
Spectral CT Imaging of Prosthetic Valve Embolization after Transcatheter Aortic Valve Implantation 44
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome 43
Myocardial ischemia due to a recanalized chronic coronary thrombus: Angiographic and optical coherence tomography imaging insights 42
How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators 39
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 37
Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score 35
Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients 35
Transfusion and Mortality After Transcatheter Aortic Valve Replacement 35
The optimal duration of dual antiplatelet therapy after coronary stent implantation: To go too far is as bad as to fall short 33
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial 32
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke 32
Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies 32
“Ticagrelor or Prasugrel, Doctor?” The Basis for Decision in Clinical Practice 31
The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19 30
Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease 29
New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine 28
null 28
Optimal Antithrombotic Regimens Across Atherosclerotic Vascular Beds: Toward Mechanism and Risk-Oriented Strategies 27
The Rotterdam radial access research: Ultrasound-based radial artery evaluation for diagnostic and therapeutic coronary procedures 26
Distal radial artery access for percutaneous coronary intervention: Convincing the sceptical cardiologist 26
Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium 25
Italian certification for interventional cardiologists from the Italian Society of Interventional Cardiology (SICI-GISE) 24
Totale 10.521
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022169 0 0 0 0 4 8 19 3 5 39 23 68
2022/2023998 31 86 40 29 70 124 18 75 488 9 22 6
2023/2024340 21 27 17 39 24 73 70 16 8 21 1 23
2024/20251.694 20 14 16 150 110 135 74 220 368 126 155 306
2025/20265.713 343 313 407 417 463 1.171 619 715 652 315 152 146
2026/20271.505 434 233 298 503 37 0 0 0 0 0 0 0
Totale 10.889